Hypertrophic cardiomyopathy and left ventricular non-compaction: Distinct diseases or variant phenotypes of a single...

Area of Science:

• Cardiology
• Genetics
• Medical Diagnostics

Background:

• Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease causing left ventricular (LV) wall thickening, potentially leading to obstruction and arrhythmias.
• Left ventricular non-compaction (LVNC) is characterized by excessive LV trabeculation and deep recesses, sometimes mimicking HCM, especially when associated with LV hypertrophy.
• Differentiating HCM from LVNC and other causes of LV hypertrophy (e.g., hypertension, aortic stenosis) can be diagnostically challenging.

Discussion:

• There is a notable overlap between HCM and LVNC, evidenced by shared genetic mutations and similar clinical manifestations.
• The diagnostic challenge lies in distinguishing between these conditions, particularly when LVNC presents with significant LV wall thickening.
• Understanding the relationship between HCM and LVNC is crucial for accurate diagnosis and patient management.

Key Insights:

• HCM is defined by LV hypertrophy not caused by external factors, often presenting with outflow obstruction or diastolic dysfunction.
• LVNC, while often benign, can lead to systolic dysfunction, thrombus formation, and arterial embolism in some cases.
• The potential for LVNC to mimic HCM highlights the complexity of diagnosing cardiomyopathies.

Outlook:

• Further investigation into the genetic and molecular underpinnings of HCM and LVNC is warranted.
• Developing advanced imaging and diagnostic criteria will improve the differentiation between these conditions.
• Clarifying the relationship between HCM and LVNC may lead to novel therapeutic strategies for overlapping patient populations.